All > Ultrasound

Liver Incytes for Non-Alcoholic Fatty Liver Disease (NAFLD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Non-Alcoholic Fatty Liver Disease (NAFLD)+1 MoreLiver Incytes - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help assess if a certain kind of liver cell can be used to help diagnose non-alcoholic fatty liver disease and its severity.

Eligible Conditions
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Non-Alcoholic Fatty Liver Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
HA35 Treatment Group
1
HTD1801
1
Group A

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: two years

two years
Correlation of Liver Incytes measurements to FibroScan® measurements for liver stiffness and liver steatosis.
Correlation of Liver Incytes measurements to liver biopsy results.
Correlation of Liver Incytes measurements to non-invasive blood markers for predicting advanced fibrosis.

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
HA35 Treatment Group
2
HTD1801
2
Group A

Trial Design

1 Treatment Group

Liver Incytes
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Liver Incytes · No Placebo Group · N/A

Liver Incytes
DiagnosticTest
Experimental Group · 1 Intervention: Liver Incytes · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: two years

Who is running the clinical trial?

Indiana UniversityLead Sponsor
876 Previous Clinical Trials
749,476 Total Patients Enrolled
Sonic IncytesIndustry Sponsor
3 Previous Clinical Trials
404 Total Patients Enrolled
Samer Gawrieh, MD4.67 ReviewsPrincipal Investigator - Indiana University School of Medicine
Indiana University Health, North Hospital, Indiana University Health, University Hospital
Medical School - University of Aleppo Faculty of Medicine, Doctor of Medicine
John H. Stroger, Jr. Hospital of Cook County, Residency in Internal Medicine
2 Previous Clinical Trials
500 Total Patients Enrolled
5Patient Review
I appreciate that he takes the time to listen to me.

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The person has suspected NAFLD or NASH and is planning to undergo a liver biopsy to confirm the diagnosis.
The person has had a biopsy that proves they have NAFLD or NASH within the last six months.
The text is saying that if someone is enrolled in the study, they will have a liver biopsy within 6 months.
You are able to provide informed consent.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top